Iberian languages

Pharming Group reports first quarter 2024 financial results and provides business update

Retrieved on: 
水曜日, 5月 8, 2024
VWAP, VUS, FDA, Phase, Haploinsufficiency, IRP, Iberian languages, Laboratory, Safety, Euronext Amsterdam, Pharmacokinetics, PTEN, Epidemiology, CTLA4, Marketing, World Games, APDS, Health care, MAA, CHMP, Trial of the century, Genetic testing, Disease, Patient, Physician, EMA, Primary immunodeficiency, Ministry, Variant, Committee, MHRA, Diagnosis, Pids, PID, Lymphocyte, Clinical trial, Government, Microsoft Access, Prevalence, Ageing, Pharmaceutical industry

“Pharming delivered a strong first quarter, increasing quarterly revenues by 31% year-over-year to US$55.6 million and keeping the Company on track for our 2024 total revenue guidance of US$280 - US$295 million.

Key Points: 
  • “Pharming delivered a strong first quarter, increasing quarterly revenues by 31% year-over-year to US$55.6 million and keeping the Company on track for our 2024 total revenue guidance of US$280 - US$295 million.
  • Pharming made continued progress in the first quarter of 2024 on leniolisib regulatory filings for APDS patients 12 years of age and older in key global markets.
  • Pharming filed regulatory submissions in Canada and Australia in the third quarter of 2023, and Israel in the second quarter.
  • Pharming announced completion of enrollment in the clinical trial for children ages 4 to 11 years old on April 8, 2024.

Pharming Group reports fourth quarter and full year 2023 financial results

Retrieved on: 
木曜日, 3月 14, 2024
Patient, Health care, Epidemiology, Executive Committee, Laboratory, Microsoft Access, Lymphocyte, Clinical trial, European Commission, APDS, MHLW, AEG, Welfare, Ageing, Committee, EMA, Trial of the century, PID, CTLA4, Safety, Pharmacokinetics, Ministry, CHMP, ODD, U.S. FDA, Prevalence, PTEN, Disease, HAE, Immunodeficiency, VUS, Literature, PIK3R1, PMDA, FDA, DSM-IV codes, Diagnosis, Civil service commission, IRP, Haploinsufficiency, Genetic testing, MAA, Autoimmunity, World Games, Iberian languages, Marketing, MHRA, Euronext Amsterdam, PIK3CD, Physician, Pharmaceutical industry

The U.S. market contributed 97% of 2023 revenues, while the EU and Rest of World contributed 3%.

Key Points: 
  • The U.S. market contributed 97% of 2023 revenues, while the EU and Rest of World contributed 3%.
  • Revenues increased to US$7.9 million in the fourth quarter of 2023, driven by the continued increase in patients on paid therapy, and revenues were US$18.2 million for 2023.
  • Pharming made continued progress in the fourth quarter of 2023 on leniolisib regulatory filings for APDS patients 12 years of age and older in key global markets.
  • Pharming filed regulatory submissions in Canada and Australia in the third quarter of 2023, and Israel in the second quarter.

HaystackID Expands Protect Analytics AI™ Suite, Advancing Cybersecurity Workflows for Investigations, Responses, and Notifications

Retrieved on: 
月曜日, 1月 29, 2024
Artificial intelligence, IDC, Protection, Warner Bros. Discovery EMEA, Name, Security, AI, Algorithm, Environment, Privacy, Iberian languages, Microsoft Power BI, Organization, Data analysis, Information, Data, LLM, Medical device

CHICAGO, Jan. 29, 2024 /PRNewswire/ -- HaystackID, a specialized eDiscovery services firm supporting law firms and corporate legal departments, announced today the expansion of its Protect Analytics AI™ Suite of artificial intelligence (AI) enabled services designed to enhance the efficiency and effectiveness of identifying, analyzing, and reporting on sensitive information within large, unstructured datasets. The enhanced suite featuring Protect Analytics AI - Sensitive Data Identification, Protect Analytics AI - Entity Extraction, and Protect Analytics AI - Deploy continues to transform cybersecurity-centric incident responses, breach investigations, and notification actions by decreasing time to precision insight and action from weeks to days and days to hours.

Key Points: 
  • The enhanced suite featuring Protect Analytics AI - Sensitive Data Identification, Protect Analytics AI - Entity Extraction, and Protect Analytics AI - Deploy continues to transform cybersecurity-centric incident responses, breach investigations, and notification actions by decreasing time to precision insight and action from weeks to days and days to hours.
  • This service also brings the power of HaystackID's analytics directly to the client's environment, enhancing data security and processing efficiency.
  • "Addressing this challenge, HaystackID continues to enhance the Protect Analytics AI Suite, delivering powerful tools like Sensitive Data Identification and the soon-to-be-released Entity Extraction and Deploy services.
  • Containerized Deployment: Protect Analytics AI Suite can be deployed in a containerized environment, making it flexible and scalable to fit into various IT infrastructures and workflows.

Parabole.ai announces the release of ESG-RC, an open-source follow-up to the popular ESG-BERT advanced ESG model

Retrieved on: 
火曜日, 9月 19, 2023
Side platform, Iberian languages, Comparative contextual analysis, Research, Classification, Parabola, TRAIN, Risk management, F1, Root cause analysis, Data, Risk, Generative, BERT, ESG, Government

PRINCETON, N.J., Sept. 19, 2023 /PRNewswire/ -- With over 1,800,000 downloads, Parabole.ai's ESG-BERT model, was one of, if not the earliest ESG-trained language models to be released to the general public. Parabole.ai extends its commitment to open source and pioneering advancements in Causal Intelligence and ESG-focused AI. Enriched through a comprehensive dataset including sustainability reports and pivotal ESG materials, ESG-BERT is trained to discover intricate ESG contexts with industry leading precision. In a benchmark study of ESG-BERT, the standard BERT model scored a F1 rating of 0.79, while the ESG-BERT model delivered a score of 0.90.

Key Points: 
  • Enriched through a comprehensive dataset including sustainability reports and pivotal ESG materials, ESG-BERT is trained to discover intricate ESG contexts with industry leading precision.
  • In a benchmark study of ESG-BERT, the standard BERT model scored a F1 rating of 0.79, while the ESG-BERT model delivered a score of 0.90.
  • ESG-RC is our much anticipated follow up to ESG-BERT, the most downloaded open source language model for ESG research.
  • This unique attribute is tailored to guide users in understanding the core dynamics behind ESG risks and opportunities.

First Horizon's Brand Campaign Clinches 8 Coveted Marketing Industry Awards

Retrieved on: 
木曜日, 7月 6, 2023
First Horizon Bank, Iberian languages, Let, John Story (cricketer)

MEMPHIS, Tenn., July 6, 2023 /PRNewswire/ -- First Horizon Bank is thrilled to announce that its Let's Find a Way brand campaign, featuring real First Horizon clients, has been honored with an exceptional tally of eight prestigious marketing industry awards. The campaign features five unique videos of real clients sharing how First Horizon has guided them to financial success. With impressive metrics, the campaign has been recognized for increasing brand awareness and impactful storytelling.

Key Points: 
  • Let's Find A Way Brand Campaign, Showcasing Real-Life Clients, Earns International Recognition
    MEMPHIS, Tenn., July 6, 2023 /PRNewswire/ -- First Horizon Bank is thrilled to announce that its Let's Find a Way brand campaign, featuring real First Horizon clients, has been honored with an exceptional tally of eight prestigious marketing industry awards.
  • The campaign features five unique videos of real clients sharing how First Horizon has guided them to financial success.
  • With impressive metrics, the campaign has been recognized for increasing brand awareness and impactful storytelling.
  • Watch the Let's Find A Way campaign videos here: Mack's Story , John's Story , Tommy's Story , Kathy's Story and Clint's Story
    "It's an honor to be recognized for the Let's Find a Way campaign," shares Erin Pryor , chief marketing officer of First Horizon Bank.

INTERNATIONALLY RECOGNIZED BOARD-CERTIFIED HAIR RESTORATION SURGEON CURATES "SLAP THE $#%& OUT OF ALOPECIA" GIFT SET, VALUED AT $7K TO BE INCLUDED IN DISTINCTIVE ASSETS "EVERYONE WINS" OSCAR NOMINEE GIFT BAG

Retrieved on: 
木曜日, 3月 2, 2023
NOT, Policy, Patient, Actor, VIP, Privacy, BET Award for best Actor & Actress of the year, Iberian languages, Philosophy, Academy of Motion Picture Arts and Sciences, PRP, Hair, Will Smith–Chris Rock slapping incident, Cosmetics, Hair loss

BOCA RATON, Fla., March 2, 2023 /PRNewswire/ -- What is commonly referred to as "The Slap Heard Around the World", or as many call it "Slapgate", has been fodder for gossip and one liners among both celebs and the masses alike is perceived in a completely different manner by Dr. Alan J. Bauman, Internationally Recognized, Full-Time, Board Certified Hair Restoration Surgeon and Founder of Bauman Medical Hair Transplant & Hair Loss Treatment Center. For Dr. Bauman, the startling and equally disturbing incident between Chris Rock and Will Smith involving Jada Pinkett Smith is an opportunity to educate people about Alopecia (the general term for hair loss) that affects 80 million Americans and how to treat the condition.

Key Points: 
  • Neither the Academy nor Distinctive Assets wants there to be any association between the "Everyone Wins" Gift Bags and the OSCARS® or the Academy.
  • This year, Hollywood's Celebrated Night of Fame is airing on March 12th and will be hosted by Jimmy Kimmel.
  • Each gift bag also includes a complimentary private one-on-one hair restoration consultation with Dr. Bauman which can be done virtually or in person.
  • While some accept or even embrace their hair loss, others simply don't want to be bald or have thinning hair.